Abstract: The present study was undertaken to investigate the protective effect of H2S against myocardial ischemiareperfusion (I/R) injury and its possible mechanism by using isolated heart perfusion and patch clamp recordings. Rat isolated hearts were Langendorff-perfused and subjected to a 30-minute ischemia insult followed by a 30-minute reperfusion. The heart function was assessed by measuring the LVDP, ±dP/dtmax, and the arrhythmia score. The results showed that the treatment of hearts with a H2S donor (40 mmol/L NaHS) during reperfusion resulted in significant improvement in heart function compared with the I/R group (LVDP recovered to 85.0% ± 6.4% vs. 35.0% ± 6.1%, +dP/dtmax recovered to 80.9% ± 4.2% vs. 43.0% ± 6.4%, and -dP/dtmax recovered to 87.4% ± 7.3% vs. 53.8% ± 4.9%; p < 0.01). The arrhythmia scores also improved in the NaHS group compared with the I/R group (1.5 ± 0.2 vs. 4.0 ± 0.4, respectively; p < 0.001). The cardioprotective effect of NaHS during reperfusion could be blocked by an ATP-sensitive potassium channel (KATP) blocker (10 mmol/L glibenclamide). In single cardiac myocytes, NaHS increased the open probability of KATP channels from 0.07 ± 0.03 to 0.15 ± 0.08 after application of 40 mmol/L NaHS and from 0.07 ± 0.03 to 0.36 ± 0.15 after application of 100 mmol/L NaHS. These findings provide the first evidence that H 2 S increases the open probability of K ATP in cardiac myocytes, which may be responsible for cardioprotection against I/R injury during reperfusion.
Introduction
Hydrogen sulfide (H 2 S) has long been recognized as a toxic gas in water and industrial air pollution. Recent studies, however, have shown that H 2 S is also an endogenous biological mediator that is generated in mammalian tissue by 2 pyridoxal-5'-phosphate-dependent enzymes, cystathionine-lyase (CSE) and cystathionine-synthase (CBS), using L-cysteine as the main substrate (Stipanuk and Beck 1982; Swaroop et al. 1992) . Indeed, it has recently been hypothesized that H 2 S is the ''third endogenous signaling gasotransmitter, alongside nitric oxide and carbon monoxide'' (Wang 2002) , which may fulfill a physiologic role in regulating cardiovascular functions. Hosoki et al. (1997) have reported that H 2 S is produced in the portal vein, thoracic aorta, tail artery, mesenteric artery, and pulmonary artery. Geng et al. (2004a) have also found that H 2 S is endogenously produced in myocardial tissues and the physiologic level of H 2 S in rat serum is approximately 45 mmol/L (Zhao et al. 2001) .
To date, the cardiovascular effects of H 2 S and its mecha-nism of action are not fully understood. In cardiovascular tissues, it has been the conventional view that H 2 S interferes with cardiovascular function as a result of secondary anoxia rather than as a direct consequence of the actions of this gas on cardiac myocytes or vascular smooth muscle cells. The results of a recent study, however, suggest that H 2 S, like other gasotransmitters, may serve as a modulator of cardiovascular function. H 2 S, at a physiologically-relevant concentration, has been demonstrated to induce relaxation of rat aortic tissue in a dose-dependent manner, including in situ endothelia and ex vivo endothelia in synergy with NO (Hosoki et al. 1997 ). The vascular effect of H 2 S may be mediated by a direct stimulation of K ATP channels and subsequent hyperpolarization of rat aortic vascular smooth muscle cells (VSMC) (Zhao et al. 2001) . It also has been found that, under normal conditions, H 2 S has a negative inotropic effect on the cardiac function of rat heart and this effect can be partly blocked by glibenclamide, a K ATP channel blocker. All the observations suggest an important physiologic role of H 2 S in the cardiovascular system and the effect of H 2 S on the cardiovascular system may be closely related to K ATP channels. It is well-known that K ATP channels are widely distributed in the myocardium. The opening of K ATP channels in the myocardium plays a pivotal role in cardioprotection during ischemia and reperfusion injury (I/R injury) and is a crucial component of the phenomenon termed cardiac ischemic preconditioning (Gross and Fryer 1999) . Recently, Johansen et al. (2006) found that treatment of rat isolated hearts with NaHS resulted in a concentration-dependent limitation of infarct size and this effect could be blocked by glibenclamide. It was thus concluded that H 2 S could protect against irreversible I/R injury and the mechanism of this action could be a function of the K ATP channel opening. In their experiments, NaHS was used from 20 min before ischemia until 10 min into the reperfusion period. No specific conclusions could be drawn about when the protection is mediated or whether H 2 S has a direct stimulatory effect on the K ATP channel.
Therefore, the present study was designed to observe the following: (i) whether H 2 S has a cardioprotective effect against I/R injury when used only during reperfusion, (ii) whether the cardioprotective effect of H 2 S during reperfusion is produced by opening the K ATP channel, and (iii) the direct effect of H 2 S on K ATP channels in single cardiac myocytes.
Materials and methods

Isolated heart preparation
Male Wistar rats (approximately 270-300 g) from the Experimental Animal Center of Capital Medical University (Beijing, China), treated in accordance with the Guide for the Care and Use of Laboratory Animals issued by the National Committee of Science and Technology of China (1988) and approved by the State Council of China (1988) , were anesthetized with 40 mg/kg pentobarbitone by i.p. injection. The hearts were quickly excised and mounted in a Langendorff apparatus and perfused retrograde via the aorta with a Krebs-Henseleit (K-H) buffer solution containing the following (in mmol/L): NaCl 120.0, KCl 4.5, NaHCO 3 20.0, KH 2 PO 4 1.2, MgCl 2 1.2, CaCl 2 1.25, and glucose 10.0, pH 7.4, at 37 8C and bubbled with 95% O 2 : 5% CO 2 at a constant flow rate of 13 mL/min, as described previously (Suzuki et al. 2000) . A saline-filled latex balloon was inserted into the cavity of the left ventricle through the left atrium. The balloon connected to a pressure transducer for the measurement of left ventricular pressure. The left ventricular diastolic pressure pro-stabilized at 5-10 mmHg. After 20 min of stabilization, the heart rate (HR), left ventricular developed pressure (LVDP, designated as the difference between the systolic and diastolic pressure of the left ventricle), and the maximal rate of left ventricular pressure development (±dP/dt max ) were measured by a BL-420E Bio-Recording System (4S Bio-med, China). The electrocardiogram was monitored continuously and recorded with 2 electrodes hooked to the apex and the aorta, respectively. Any heart that exhibited arrhythmias during this period was discarded.
The experimental design and protocols are shown in Fig. 1A . In the control group (I/R group, n = 9), the hearts were perfused for 20 min with K-H solution and then subjected to an ischemic insult (no perfusion for 30 min) followed by 30 min of reperfusion. For the NaHS group (n = 8), the physiologic concentration of NaHS (40 mmol/L) was applied continuously during 30 min of reperfusion. In the K ATP channel blocker group (n = 7), perfusion with glibenclamide (10 mmol/L) began at the same time as reperfusion, but 5 min before adding NaHS. The parameters of cardiac function in the various groups were measured.
Arrhythmia scoring system
To quantify arrhythmias, the scoring system of Curtis and Walker was used according to Bian's modifications (Bian et al. 2006) . Since the arrhythmias induced by I/R in this study were mainly ventricular premature beats and ventricular tachycardia (VT), the scoring emphasis was placed on ventricular arrhythmias. The scoring system adopted was as follows: 0, no arrhythmia; 1, approximately 1-30 premature ventricular contractions (PVC); 2, >30 PVC; 3, <3 episodes of ventricular fibrillation (VF) and (or) VT; 4, 3-5 episodes of VF and (or) VT; and 5, >5 episodes of VF and (or) VT. VT was defined as 4 or more consecutive premature beats of ventricular origin, and ventricular fibrillation was defined as a signal in which individual QRS deflections could no longer be distinguished from one another and for which the rate could not be determined. The score of a particular heart was the value of the most severe type of arrhythmias exhibited during 10 min of reperfusion.
Preparation of single ventricular myocytes
Single cardiac myocytes were isolated from the hearts by using a collagenase perfusion method, as described previously (Lee et al. 1999) . Briefly, the hearts were excised and placed immediately in ice-cold, nominally Ca 2+ -free Tyrode solution that contained the following (in mmol/L): 138.0 NaCl, 4.5 KCl, 0.5 MgCl 2 , 0.33 Na 2 HPO 4 , 5.5 glucose, and 10.0 HEPES (pH 7.38 with NaOH). The hearts were perfused by using a Langendorff apparatus with nominally Tyrode solution for 3 min at 37 8C and then Ca 2+ -free Tyrode solution for another 5 min. The perfusate was changed to nominally containing 1 mg/mL collagenase type II (Worthington Biochemical) and 0.1% (w/v) BSA for 20-25 min at 37 8C. The hearts were cut into small pieces and filtered through a medium mesh. Single cells were maintained at 4 8C in KB (Kraft-Brühe) solution which contained the following (in mmol/L): 70.0 KOH, 40.0 KCl, 50.0 L-glutamic acid, 20.0 taurine, 0.5 MgCl 2 , 1.0 K 2 HPO 4 , 0.5 EGTA, 10.0 HEPES, 5.0 creatine, and 5.0 pyruvic acid (pH 7.38 with KOH). All solutions were vigorously oxygenated for 30 min before use.
Electrophysiological recordings
Unitary currents of K ATP channels in rat ventricular myocytes were recorded with an inside-out patch-clamp configuration (Hamill et al. 1981) . Isolated myocytes were placed in a chamber (0.5 mL) on the stage of an inverted microscope and were superfused at approximately 1-2 mL/min with a bath solution that contained the following (in mmol/L): 
Statistical methods
Data are presented as the means ± SE. Student's paired t test was used to compare data obtained before and after an intervention. One-way ANOVA followed by contrast testing was used to compare data from multiple groups. Statistical significance was assumed at p < 0.05.
All drugs were purchased from Sigma (St. Louis, Mo.). A stock solution of NaHS and glibenclamide were freshly prepared immediately before use.
Results
H 2 S attenuated I/R-induced cardiac dysfunction
This series of experiments was undertaken to determine whether H 2 S (only used during reperfusion) was able to protect cardiac function against I/R injury. Like numerous previous researchers, we utilized NaHS as a soluble H 2 S donor. As shown in Figs. 1B, 1C, and 1D, ischemia caused LVDP and ±dP/dt max to be reduced to zero level within 5 min. After reperfusion, heart function partially recovered (compared with the normal level, LVDP recovered to 35.0% ± 6.1%, +dP/dt max recovered to 43.0% ± 6.4%, and -dP/dt max recovered to 53.8% ± 4.9% (n = 9); p < 0.01).
The H 2 S concentration of rat serum was reported to be 45.6 mmol/L (Zhao et al. 2001 ). NaHS at 40 mmol/L, which was relevant to the rat serum physiologic concentration, was applied continuously during reperfusion. NaHS improved the cardiac function (LVDP recovered to 85.0% ± 6.4%, +dP/ dt max recovered to 80.9% ± 4.2%, and -dP/dt max recovered to 87.4% ± 7.3% compared with the I/R group (n = 8); p < 0.01). These results suggest that using H 2 S during reperfusion also has a protective effect for the cardiac function against I/R injury. Figure 2 shows that H 2 S protected the heart against I/Rinduced arrhythmias significantly. The arrhythmia scores during the 30 min reperfusion period were significantly decreased in the NaHS group compared with the I/R group (1.5 ± 0.2 vs. 4.0 ± 0.4, respectively; p < 0.001).
H 2 S attenuated I/R-induced arrhythmias
Inhibition of K ATP channels blocks the cardioprotective effect of H 2 S
It was reported that on VSMCs, H 2 S opens the K ATP channel, increases the K ATP channel currents, and hyperpolarizes the membrane, resulting in vascular smooth muscle relaxation. Geng et al. (2004a) reported that under normal conditions, H 2 S regulates the cardiac function, which is mediated by the K ATP channel pathway. Johansen et al. (2006) also found that treatment with NaHS resulted in a concentration-dependent limitation of infarct size induced by I/R injury and this effect could be blocked by glibenclamide. Therefore, we also examined the role of the K ATP channel in the cardioprotective action of H 2 S during reperfusion. Pre-administration of 10 mmol/L glibenclamide (a K ATP channel blocker) 5 min before the reperfusion of NaHS, led to abrogation of the protective effects of H 2 S (Figs. 1B, 1C,  and 1D, Fig. 2) .
Effects of exogenous H 2 S on K ATP channels in single cardiac myocytes
Our results and other reports (Suzuki et al. 2000) have demonstrated that the protective effect of H 2 S may be involved in the opening of K ATP. Until now, however, no evidence has shown the effect of H 2 S on K ATP directly. In inside-out membrane patches, K ATP channel activity was shown after the patches were excised. But it decreased quickly and the activity was hardly detectable after excision of the membrane. In the presence of symmetrical K + (140 mmol/L) and a low cytoplasmic ATP concentration (0.1 mmol/L; this concentration of ATP can prevent rundown of this channel during a relatively long period), the inside-out recordings from single rat ventricular myocytes showed flickering channel openings with single channel amplitudes of 5.1 ± 0.5 pA at -60 mV (Fig. 3) . Channel activity was totally suppressed by 5 mmol/L ATP and this inhibition was readily reversible upon washout of ATP (data Fig. 2 . Effects of NaHS on cardiac rhythm during ischemiareperfusion (I/R) injury. NaHS perfusion during reperfusion significantly decreased the arrhythmia scores compared with those in the control I/R group (n = 9), and this effect could be blocked by glibenclamide (10 mmol/L). Values are means ± SE; **, p < 0.001 vs. control I/R. No significant difference was found between the I/R and Gli+NaHS groups. not shown). Thus, the K ATP channel currents were identified by the unitary current amplitude and by inhibition with 5 mmol/L ATP.
To determine the direct effects of exogenous H 2 S on the cardiac myocyte K ATP channel, different concentrations of NaHS were used. As shown in Fig. 3 , NaHS significantly increased the open probability (Po) of single K ATP channels. NaHS at 40 mmol/L increased the Po of K ATP channels from 0.07 ± 0.03 to 0.15 ± 0.08 (n = 5). NaHS does not affect the channel conductance. The effects of NaHS could be blocked by glibenclamide (10 mmol/L).
Discussion
As an endogenous production, it was reported that H 2 S modulates the N-methyl-D-aspartate (NMDA) receptormediated responses by the second messenger-cyclic AMP on neuron cells (Kimura 2000) . Similar to NO and CO, H 2 S is responsible for neuronal excitation by Ca 2+ and a calmodulin-mediated pathway (Eto et al. 2002 ). In the VSMCs, H 2 S opens the K ATP channel, increases the K ATP channel currents, and hyperpolarizes the membrane, resulting in vascular smooth muscle relaxation. These effects were partly mediated by functional endothelium and dependent on extracellular calcium entry, which differed from NO and CO, the prostaglandins, protein kinase C, cAMP, and cGMP pathways (Zhao et al. 2001; Zhao and Wang 2002) .
In this study, we examined the role of the K ATP channel pathway in cardioprotection (in terms of cardiac function and arrhythmia) of an exogenous application of NaHS (a precursor of H 2 S) during the reperfusion period. As is known, approximate endogenous levels of H 2 S are 50-160 mmol/L in rat brain, 46 mmol/L in Sprague-Dawley rat plasma, 10-100 mmol/L in human blood (Richardson et al. 2000) , and 300 mmol/L in rat pulmonary artery VSMCs (Zhang et al. 2003) . Thus, the H 2 S concentration (approximately 40-100 mmol/L) used in the present study was within the range of the physiologic concentration. The results showed that reperfusion with NaHS after ischemia attenuated arrhythmias in the isolated Langendorff-perfused heart and improved cardiac function during I/R; these effects could be blocked by the K ATP channel blocker glibenclamide. These data suggested that at a physiologic concentration, H 2 S produces a cardioprotective effect against I/R injury during reperfusion, at least partially by opening K ATP channels. This is the first evidence to show that K ATP channels opening solely at reperfusion are capable of improving cardiac function.
Subsequently, we examined the effect of H 2 S on K ATP channels by using a patch clamp method to ensure that H 2 S had an effect by a stimulatory action on K ATP channels. Single-channel data reflect more convincing electrophysiological features of K ATP channels. The single K ATP channel amplitude was 5.1 ± 0.5 pA under symmetrical condition at -60 mV. These features are consistent with a previous report (Terzic et al. 1995) in cardiac cells. Perfusing single cardiac myocytes with NaHS increased the single-channel activity of K ATP channels by increasing the open probability of K ATP channels without altering single-channel conductance. This increase in the open probability can be blocked by glibenclamide (Fig. 3) .
Reports have shown that H 2 S may protect the heart against arrhythmias by scavenging reactive oxygen species (ROS) (Geng et al. 2004b ) and opening K ATP channels (Zhao et al. 2001) , which reduce calcium influx and shorten the action potential duration (APD). Opening of the K ATP channel by H 2 S would be expected to enhance shortening of the cardiac APD by accelerating repolarization phase 3, thereby inhibiting Ca 2+ entry into the cell via L-type channels and preventing Ca 2+ overload. Furthermore, the slowing of depolarization would also be expected to reduce Ca 2+ entry and slow or prevent the reversal of the Na + /Ca 2+ exchanger. The resultant decrease in Ca 2+ influx would be expected to lead to a reduction of the mechanical contraction, blunting of intracellular Ca 2+ overload, and energy sparing during ischemia and reperfusion, which may protect cell function via a reduction in Ca 2+ overload during ischemia and reperfusion.
The mechanism of the effect of H 2 S on K ATP channels was not investigated in this experiment. It has been reported that H 2 S at a physiological concentration inhibited cytochrome c oxidase, an enzyme critical for oxidative phosphorylation of mitochondrial respiration, and led to the depletion of [ATP] i (Dorman et al. 2002) . But in our study, the effect of H 2 S did not appear to be caused by the direct depletion of [ATP] i because in patch clamp experiments, [ATP] i was clamped to 0.1 mmol/L. Nonetheless, H 2 S can open K ATP . Thus, an alternation of intracellular ATP concentration cannot explain the interaction between H 2 S and K ATP channels. In other words, the activation of K ATP channels by H 2 S was unlikely to result from the reduction of [ATP] i . It is possible that H 2 S directly interacted with K ATP channel proteins by reducing the cysteine residues. The molecular mechanisms underlying the effect of H 2 S on K ATP channels and the transduction signal are still in need of further investigation.
In conclusion, the present study has demonstrated that exogenous H 2 S contributes to cardioprotection against I/R injury at reperfusion. At the single channel level, H 2 S can open the K ATP channel, which may be responsible for its cardioprotective effect. As a novel gasotransmitter, the pathophysiological regulatory action of H 2 S merits further investigation in cardiovascular disease.
